RESUMO
We propose a new approach for measuring ventilation air exchange rates (AERs). The method belongs to the class of tracer gas techniques, but is formulated in the light of systems theory and signal processing. Unlike conventional CO2 based methods that assume the outdoor ambient CO2 concentration is constant, the proposed method recognizes that photosynthesis and respiration cycle of plants and processes associated with fuel combustion produce daily, quasi-periodic, variations in the ambient CO2 concentrations. These daily variations, which are within the detection range of existing monitoring equipment, are utilized for estimating ventilation rates without the need of a source of CO2 in the building. Using a naturally-ventilated residential apartment, AERs obtained using the new method compared favorably (within 10%) to those obtained using the conventional CO2 decay fitting technique. The new method has the advantages that no tracer gas injection is needed, and high time resolution results are obtained.
RESUMO
SARS-CoV-2 transmission occurs mainly indoors, through virus-laden airborne particles. Although the presence and infectivity of SARS-CoV-2 in aerosol are now acknowledged, the underlying circumstances for its occurrence are still under investigation. The contamination of domiciliary environments during the isolation of SARS-CoV-2-infected patients in their respective rooms in individual houses and in a nursing home was investigated by collecting surface and air samples in these environments. Surface contamination was detected in different contexts, both on high and low-touch surfaces. To determine the presence of virus particles in the air, two sampling methodologies were used: air and deposition sampling. Positive deposition samples were found in sampling locations above the patient's height, and SARS-CoV-2 RNA was detected in impactation air samples within a size fraction below 2.5 µm. Surface samples rendered the highest positivity rate and persistence for a longer period. The presence of aerosolized SARS-CoV-2 RNA occurred mainly in deposition samples and closer to symptom onset. To evaluate the infectivity of selected positive samples, SARS-CoV-2 viability assays were performed, but our study was not able to validate the virus viability. The presented results confirm the presence of aerosolized SARS-CoV-2 RNA in indoor compartments occupied by COVID-19 patients with mild symptoms, in the absence of aerosol-generating clinical procedures.